Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-29

Clinical Trial Update: Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intensity-modulated radiation therapy (IMRT) for non-anaplastic non-medullary thyroid cancer has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Thyroid Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-12-29